Welcome to LookChem.com Sign In|Join Free
  • or
benzyl 2-(difluoromethoxy)acetate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1089709-30-7

Post Buying Request

1089709-30-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1089709-30-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1089709-30-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,8,9,7,0 and 9 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1089709-30:
(9*1)+(8*0)+(7*8)+(6*9)+(5*7)+(4*0)+(3*9)+(2*3)+(1*0)=187
187 % 10 = 7
So 1089709-30-7 is a valid CAS Registry Number.

1089709-30-7Downstream Products

1089709-30-7Relevant academic research and scientific papers

Copper-Catalyzed O-Difluoromethylation of Functionalized Aliphatic Alcohols: Access to Complex Organic Molecules with an OCF2H Group

Levchenko, Kostiantyn,Datsenko, Olexandr P.,Serhiichuk, Oleh,Tolmachev, Andrei,Iaroshenko, Viktor O.,Mykhailiuk, Pavel K.

, p. 5803 - 5813 (2016/07/23)

A two-step synthetic strategy toward difluoromethyl ethers via a CuI-catalyzed reaction of the alcohols, bearing additional protected functionalities, with FSO2CF2CO2H has been developed. The high potential of the developed protocol has been shown by preparing novel OCF2H-analogues of GABA and l-proline. The described transformation has good functional group compatibility and can serve as a powerful synthetic tool for late-stage preparation of complex OCF2H-containing organic compounds as well as building blocks for drug discovery.

NOVEL COMPOUNDS

-

Page/Page column 61, (2015/12/17)

Disclosed are novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORγ.

SUBSTITUTED HYDROXYETHYL AMINE COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE

-

Page/Page column 224-225, (2009/01/20)

The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula I or Formula II wherein RIa, RIb, RIc, B, R3, R4, R5 and W of Formula I, and RIa, RIb, RIc, R2, R2a, R3, R4, R5, R6, Al, A2, A3, A4, W, X, Z, m and n of Formula II are defined herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1089709-30-7